News from AMRI A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( NASDAQ-NMS:AMRI)

Feb 09, 2016, 08:00 ET

AMRI to Announce Fourth Quarter and Full Year 2015 Results

 AMRI (NASDAQ: AMRI) today announced it will issue fourth quarter and full year 2015 financial results before the opening of the market on...

Feb 04, 2016, 16:05 ET

AMRI Appoints Anthony J. Maddaluna to Board of Directors

 AMRI (NASDAQ: AMRI) today announced that Anthony J. Maddaluna, Executive Vice President of Pfizer Inc. and President of Pfizer Global...

Jan 20, 2016, 08:45 ET

AMRI Announces Executive Hire to Lead Active Pharmaceutical Ingredients Business

 AMRI (NASDAQ: AMRI) announced today that Dawn M. Von Rohr, will join AMRI as Sr. Vice President, API, effective January 25, 2016....

Jan 14, 2016, 08:00 ET

AMRI and NYCNMR Form Collaborative Agreement

 Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that it has signed a collaboration agreement with the New York Center for...

Jan 12, 2016, 07:00 ET

AMRI Announces 3-Year Extension of Insourcing Contract

 AMRI (NASDAQ: AMRI) is pleased to announce the extension of a key insourcing relationship with a major pharmaceutical company designed to...

Jan 11, 2016, 06:45 ET

AMRI Announces First Product Approval Out of its Massachusetts Aseptic Fill Finish Site

 AMRI (NASDAQ: AMRI) announced that Docetaxel Injection (non-alcohol formula) has been approved for commercial manufacture at its Burlington,...

Jan 10, 2016, 18:00 ET

AMRI Date and Time Change for J.P. Morgan Healthcare Conference Presentation

 Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, AMRI's President and Chief Executive Officer, will...

Jan 07, 2016, 11:03 ET

AMRI and Icagen Ink Collaboration Agreement

 Albany Molecular Research Inc. (NASDAQ: AMRI) and Icagen, Inc. announced today that they have signed a collaboration agreement to co-market...

Jan 04, 2016, 08:00 ET

AMRI CEO to Present at the 34th Annual J.P. Morgan Healthcare Conference

Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, AMRI's President and Chief Executive Officer, will present at...

Dec 15, 2015, 08:13 ET

AMRI Acquires Whitehouse Laboratories

 AMRI (NASDAQ: AMRI) today announced that it has acquired all the outstanding equity interests of Whitehouse Laboratories, a leading provider...

Dec 10, 2015, 08:00 ET

AMRI and Multispan Ink Collaboration Agreement

 Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that it has signed a collaboration agreement with biotechnology company...

Dec 07, 2015, 08:00 ET

AMRI Launches its U.S. Integrated Drug Discovery Center

Albany Molecular Research Inc. (NASDAQ: AMRI) today introduces its new U.S.-based integrated drug discovery center in Buffalo, N.Y. Located on the...

Nov 13, 2015, 08:00 ET

AMRI CEO to Present at Jefferies Autumn 2015 Global Healthcare Conference London

 Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, AMRI's President and Chief Executive Officer, will...

Nov 05, 2015, 07:00 ET

AMRI Announces Third Quarter 2015 Results

AMRI (NASDAQ: AMRI) today reported financial and operating results for the third quarter ended September 30 2015. Highlights: - Third...

Oct 29, 2015, 08:00 ET

AMRI to Present at Credit Suisse Healthcare Conference

 Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, AMRI's President and Chief Executive Officer, will...

Oct 20, 2015, 08:00 ET

AMRI to Announce Third Quarter 2015 Results

 AMRI (NASDAQ: AMRI) today announced it will issue third quarter 2015 financial results before the opening of the market on Thursday, November...

Sep 15, 2015, 10:48 ET

AMRI Updates 2015 Financial Guidance Following Gadea Acquisition

 Following the acquisition of Gadea Pharmaceutical Group, AMRI (NASDAQ: AMRI) has updated guidance for full year 2015. "We are very pleased...

Sep 14, 2015, 08:00 ET

AMRI Promotes Two Company Executives to Key Positions

 AMRI (NASDAQ: AMRI) today announced two promotions within the company's senior management team. George Svokos, Senior Vice President and Chief...

Sep 03, 2015, 08:00 ET

AMRI Appoints Christopher Conway to Lead AMRI Global Discovery and Development Services Business; Names Vice President of Discovery Biology and Pharmacology

 AMRI (NASDAQ: AMRI) is pleased to announce that it has appointed Christopher Conway as Senior Vice President of Discovery and Development and...

Sep 02, 2015, 08:29 ET

AMRI to Present at Morgan Stanley Global Healthcare Conference 2015

 Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, AMRI's President and Chief Executive Officer, will...